← Leaderboards
Frances Rudnick Levin
Columbia University Health Sciences
$39,078,718
Attributed
$53,462,516
Total exposure
22
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$70,927,696 · 23
AHRQ$278,461 · 1
By mechanism
U01$20,738,495 · 4
U54$17,222,258 · 2
R01$12,014,969 · 8
T32$8,272,888 · 1
P50$5,012,605 · 2
UG3$4,041,131 · 2
Top collaborators
- Kenneth Michael Carpenter5 shared
- Kathleen Theresa Brady4 shared
- Diana M Martinez4 shared
- Edward V Nunes4 shared
- Sandra Ann Springer4 shared
- Daniel Levy3 shared
- Lawrence R Toll3 shared
- Sandra D. Comer1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Deborah S. Hasin$40,571,837
- Charles W Emala$16,701,773
- Edward V Nunes$88,947,598
- Jonathan A Javitch$40,288,430
- Mary Sano$40,764,266
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsCocaineSubstance Abuse ProblemResearch PersonnelClinical ResearchClinical TrialsPlacebosBasePharmacotherapyRandomizedFundingRelapseCravingAddictionProgramsTrainingNational Institute Of Drug AbuseLaboratoriesComorbidityInnovationAbstinenceSiteSubstance Use DisorderAdult
Grant awards (113)
Translational Clinical Research Fellowship on Substance Use Disorders$583,301
T32 · FY2025 · DA · contact PI
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder$3,623,079
U01 · FY2024 · DA
Translational Clinical Research Fellowship on Substance Use Disorders$412,899
T32 · FY2024 · DA · contact PI
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder$2,380,269
U01 · FY2023 · DA
Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies$1,253,950
U01 · FY2023 · DA · contact PI
Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder$728,927
UG3 · FY2023 · DA
Translational Clinical Research Fellowship on Substance Use Disorders$541,874
T32 · FY2023 · DA · contact PI
Phase 1 and 2 studies of sublingual dexmedetomidine, an alpha 2 adrenergic agonist, for treating opioid withdrawal$3,312,204
UG3 · FY2022 · DA · contact PI
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder$2,680,161
U01 · FY2022 · DA
Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies$1,635,195
U01 · FY2022 · DA · contact PI
Coordinated medical treatment of opioid use disorder and infectious disease$1,267,815
U01 · FY2022 · TR
Translational Clinical Research Fellowship on Substance Use Disorders$512,560
T32 · FY2022 · DA · contact PI
The CB1 Signaling-Specific Inhibitor, AEF0117, for Cannabis Use Disorder: A Multi-Site Treatment Trial$1,594,372
U01 · FY2021 · DA · contact PI
Coordinated medical treatment of opioid use disorder and infectious disease$1,347,367
U01 · FY2021 · TR
Translational Clinical Research Fellowship on Substance Use Disorders$409,328
T32 · FY2021 · DA · contact PI
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues$198,875
R21 · FY2021 · DA · contact PI
Coordinated medical treatment of opioid use disorder and infectious disease$1,353,900
U01 · FY2020 · TR
Research Fellowship in Substance Abuse Disorder$476,332
T32 · FY2020 · DA · contact PI
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues$238,650
R21 · FY2020 · DA · contact PI
Coordinated medical treatment of opioid use disorder and infectious disease$1,450,097
U01 · FY2019 · TR
Research Fellowship in Substance Abuse Disorder$454,753
T32 · FY2019 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$173,872
K24 · FY2019 · DA · contact PI
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders$2,977,298
U54 · FY2018 · DA · contact PI
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence$672,426
R01 · FY2018 · DA
Research Fellowship in Substance Abuse Disorder$438,398
T32 · FY2018 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$175,661
K24 · FY2018 · DA · contact PI
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders$2,899,358
U54 · FY2017 · DA · contact PI
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence$685,383
R01 · FY2017 · DA
Research Fellowship in Substance Abuse Disorder$401,566
T32 · FY2017 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$173,042
K24 · FY2017 · DA · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$20,000
R13 · FY2017 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$1
T32 · FY2017 · DA · contact PI
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders$2,893,962
U54 · FY2016 · DA · contact PI
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence$680,333
R01 · FY2016 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$400,179
T32 · FY2016 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$172,329
K24 · FY2016 · DA · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$25,000
R13 · FY2016 · DA · contact PI
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders$2,858,222
U54 · FY2015 · DA · contact PI
Administrative Core$1,517,284
U54 · FY2015 · DA · contact PI
1/2-Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence$687,359
U01 · FY2015 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$384,409
T32 · FY2015 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$173,526
K24 · FY2015 · DA · contact PI
Advancing Patient-Centered Outcomes in Addiction Psychiatry Practice$92,557
R18 · FY2015 · HS · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$25,000
R13 · FY2015 · DA · contact PI
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders$2,666,246
U54 · FY2014 · DA · contact PI
Administrative Core$1,409,888
U54 · FY2014 · DA · contact PI
1/2-Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence$715,164
U01 · FY2014 · DA · contact PI
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence$709,279
R01 · FY2014 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$192,572
K24 · FY2014 · DA · contact PI
Advancing Patient-Centered Outcomes in Addiction Psychiatry Practice$93,044
R18 · FY2014 · HS · contact PI
Research Fellowship in Substance Abuse Disorder$73,465
T32 · FY2014 · DA · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$25,000
R13 · FY2014 · DA · contact PI
1/2-Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence$749,767
U01 · FY2013 · DA · contact PI
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence$734,190
R01 · FY2013 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$332,983
T32 · FY2013 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$192,572
K24 · FY2013 · DA · contact PI
Advancing Patient-Centered Outcomes in Addiction Psychiatry Practice$92,860
R18 · FY2013 · HS · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$25,000
R13 · FY2013 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$342,074
T32 · FY2012 · DA · contact PI
Multi-Site Controlled Trial of Cocaine Vaccine (6 of 6) Columbia University Site$278,294
R01 · FY2012 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$192,572
K24 · FY2012 · DA · contact PI
American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium$25,000
R13 · FY2012 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$385,512
T32 · FY2011 · DA · contact PI
Multi-Site Controlled Trial of Cocaine Vaccine (6 of 6) Columbia University Site$338,040
R01 · FY2011 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$192,572
K24 · FY2011 · DA · contact PI
Multi-Site Controlled Trial of Cocaine Vaccine (6 of 6) Columbia University Site$90,208
R01 · FY2011 · DA · contact PI
Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence$540,042
R01 · FY2010 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$329,607
T32 · FY2010 · DA · contact PI
Substance Abuse Treatment Development and Clinical Research Mentoring$178,902
K24 · FY2010 · DA · contact PI
Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence$540,693
R01 · FY2009 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$378,838
T32 · FY2009 · DA · contact PI
Treatment of Substance Abuse and Psychiatric Comorbidity$122,861
K02 · FY2009 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$54,014
T32 · FY2009 · DA · contact PI
Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence$525,325
R01 · FY2008 · DA · contact PI
Multi-Site Controlled Trial of Cocaine Vaccine (6 of 6) Columbia University Site$363,178
R01 · FY2008 · DA · contact PI
Combined Pharmacotherapies for Cocaine Dependence$329,961
R01 · FY2008 · DA · contact PI
Research Fellowship in Substance Abuse Disorder$326,224
T32 · FY2008 · DA · contact PI
Agonist Treatment for Marijuana Dependence$324,159
P50 · FY2008 · DA · contact PI
Treatment of Substance Abuse and Psychiatric Comorbidity$122,861
K02 · FY2008 · DA · contact PI
Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence$526,408
R01 · FY2007 · DA · contact PI
Agonist Treatment for Marijuana Dependence$432,671
P50 · FY2007 · DA · contact PI
Combined Pharmacotherapies for Cocaine Dependence$336,456
R01 · FY2007 · DA · contact PI
Research Fellowship in Substance Abuse Disorders$312,221
T32 · FY2007 · DA · contact PI
Treatment of Substance Abuse and Psychiatric Comorbidity$122,861
K02 · FY2007 · DA · contact PI
Marijuana Dependence & Depression: Venlafaxine Treatment$460,755
R01 · FY2006 · DA · contact PI
Combined Pharmacotherapies for Cocaine Dependence$346,505
R01 · FY2006 · DA · contact PI
Research Fellowship in Substance Abuse Disorders$308,748
T32 · FY2006 · DA · contact PI
Agonist Treatment for Marijuana Dependence$275,266
P50 · FY2006 · DA · contact PI
Treatment of Substance Abuse and Psychiatric Comorbidity$122,861
K02 · FY2006 · DA · contact PI
Marijuana Dependence & Depression: Venlafaxine Treatment$6,644
R01 · FY2006 · DA · contact PI
Marijuana Dependence &Depression: Venlafaxine Treatment$464,665
R01 · FY2005 · DA
Agonist Treatment for Marijuana Dependence$267,255
P50 · FY2005 · DA
Research Fellowship in Substance Abuse Disorders$258,965
T32 · FY2005 · DA
Treatment of Substance Abuse and Psychiatric Comorbidity$122,861
K02 · FY2005 · DA
Marijuana Dependence &Depression: Venlafaxine Treatment$444,959
R01 · FY2004 · DA
Agonist Treatment for Marijuana Dependence$264,699
P50 · FY2004 · DA
Research Fellowship in Substance Abuse Disorders$154,637
T32 · FY2004 · DA
TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY$122,180
K02 · FY2004 · DA
Marijuana Abusing ADHD Teens: Atomoxetine Treatment$108,981
R01 · FY2004 · DA
NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE$1,182,508
P50 · FY2003 · DA
Marijuana Dependence &Depression: Venlafaxine Treatment$441,179
R01 · FY2003 · DA
TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY$122,180
K02 · FY2003 · DA
NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE$1,157,895
P50 · FY2002 · DA
TREATMENT OF ADULT ADHD IN METHADONE PATIENTS$528,706
R01 · FY2002 · DA
METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD$249,069
R01 · FY2002 · DA
TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY$122,180
K02 · FY2002 · DA
NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE$1,108,152
P50 · FY2001 · DA
TREATMENT OF ADULT ADHD IN METHADONE PATIENTS$549,103
R01 · FY2001 · DA
METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD$202,574
R01 · FY2001 · DA
TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY$122,180
K02 · FY2001 · DA
TREATMENT OF ADULT ADHD IN METHADONE PATIENTS$533,113
R01 · FY2000 · DA
METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD$328,500
R01 · FY2000 · DA
TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY$122,180
K02 · FY2000 · DA